Irreversible Inhibition Kinetics1 Automation and Simulation Petr Kuzmič, Ph.D. BioKin, Ltd. 1.Automate the determination of biochemical parameters 2.PK/PD.

Slides:



Advertisements
Similar presentations
Enzymes What are enzymes?
Advertisements

Petr Kuzmič, Ph.D. BioKin, Ltd.
Determination of Binding Affinities and Molecular Mechanisms
Determination of Binding Affinities and Molecular Mechanisms Petr Kuzmič BioKin, Ltd. Part 1: Theory Training Day May 2, 2014 (London)
Kinetics: Reaction Order Reaction Order: the number of reactant molecules that need to come together to generate a product. A unimolecular S  P reaction.
Petr Kuzmič, Ph.D. BioKin, Ltd. WATERTOWN, MASSACHUSETTS, U.S.A. Binding and Kinetics for Experimental Biologists Lecture 8 Optimal design of experiments.
ENZYMES: KINETICS, INHIBITION, REGULATION
Petr Kuzmič, Ph.D. BioKin, Ltd. New Insights into Covalent Enzyme Inhibition December 5, 2014 Brandeis University Application to Anti-Cancer Drug Design.
Petr Kuzmič, Ph.D. BioKin, Ltd. WATERTOWN, MASSACHUSETTS, U.S.A. Binding and Kinetics for Experimental Biologists Lecture 1 Numerical Models for Biomolecular.
Enzyme Kinetics, Inhibition, and Control
Elementary Chemical Kinetics ( )
Petr Kuzmič, Ph.D. BioKin, Ltd. WATERTOWN, MASSACHUSETTS, U.S.A. Binding and Kinetics for Experimental Biologists Lecture 7 Dealing with uncertainty: Confidence.
Lehninger Principles of Biochemistry
WATERTOWN, MASSACHUSETTS, U.S.A.
Why IC50’s Are Bad for You And Other Surprises
Numerical Enzyme Kinetics using DynaFit software
Steady-State Enzyme Kinetics1 A New 'Microscopic' Look at Steady-state Enzyme Kinetics Petr Kuzmič BioKin Ltd. SEMINAR: University.
Biochemistry Lecture 8.
Covalent Inhibition Kinetics Application to EGFR Kinase
 The active site have a rigid shape.  Only substrates with the matching shape can fit.  The substrate is a key that fits the lock of the active site.
Lecture 14: Regulation of Proteins 1: Allosteric Control of ATCase
Medical Biochemistry, Lecture 24
Identify and Investigate the role of enzymes.
Numerical Enzymology Generalized Treatment of Kinetics & Equilibria Petr Kuzmič, Ph.D. BioKin, Ltd. DYNAFIT SOFTWARE PACKAGE.
Binding and Kinetics for Experimental Biologists Lecture 2 Evolutionary Computing : Initial Estimate Problem Petr Kuzmič, Ph.D. BioKin, Ltd. WATERTOWN,
Reviewed by Sahar and Pablo
Inhibited Enzyme Kinetics Inhibitors may bind to enzyme and reduce their activity. Enzyme inhibition may be reversible or irreversible. For reversible.
Enzyme activity is measured by the amount of product produced or the amount of substrate consumed. The rate of the enzymatic reaction is measured by the.
ENZYME KINETIC M. Saifur R, PhD. Course content  Enzymatic reaction  Rate of Enzyme-Catalyzed Reactions  Quatification of Substrate Concentration and.
ENZYMES A catalyst Is a chemical agent that speeds up a reaction without being consumed by the reaction An enzyme is an organic catalyst Enzymes are proteins.
Kinetic Analysis of Tyrosinase Enzyme
Biochemical / Biophysical Kinetics “Made Easy” Software DYNAFIT in drug discovery research Petr Kuzmič, Ph.D. BioKin, Ltd. 1.Theory: differential equation.
WATERTOWN, MASSACHUSETTS, U.S.A.
Optimal Experiment Design for Dose-Response Screening of Enzyme Inhibitors Petr Kuzmic, Ph.D. BioKin, Ltd. WATERTOWN, MASSACHUSETTS, U.S.A. Most assays.
Numerical Enzymology Generalized Treatment of Kinetics & Equilibria Petr Kuzmič, Ph.D. BioKin, Ltd. 1.Overview of recent applications 2.Selected examples.
Modeling and identification of biological networks Esa Pitkänen Seminar on Computational Systems Biology Department of Computer Science University.
Advanced Methods in Dose-Response Screening of Enzyme Inhibitors 1. Fitting model: Four-parameter logistic (IC 50 ) vs. Morrison equation (K i *) 2. Robust.
Biochemical Kinetics Made Easier Petr Kuzmič, Ph.D. BioKin, Ltd. 1.Theory: differential equations - DYNAFIT software 2.Example I: Initial rate experiment.
Competitive Inhibition &
BIOINFORMATICS ON NETWORKS Nick Sahinidis University of Illinois at Urbana-Champaign Chemical and Biomolecular Engineering.
Why study enzyme kinetics?  To quantitate enzyme characteristics  define substrate and inhibitor affinities  define maximum catalytic rates  Describe.
Biochemistry Lecture 8. Why Enzymes? Higher reaction rates Greater reaction specificity Milder reaction conditions Capacity for regulation Metabolites.
Allosteric Enzymes • Allosteric enzymes have one or more allosteric sites • Allosteric sites are binding sites distinct from an enzyme’s active site or.
Picture of an enzymatic reaction. Velocity =  P/  t or -  S/  t Product Time.
Influence of product adsorption on catalytic reaction determined by Michaelis-Menten kinetics Šebojka Komorsky-Lovrić and Milivoj Lovrić Department of.
2 Enzymes The Hill equation describes the behavior of enzymes that exhibit cooperative binding of substrate 1. some enzymes bind their substrates.
Bio/Chemical Kinetics Made Easy A Numerical Approach Petr Kuzmič, Ph.D. BioKin, Ltd. 1. Case study: Inhibition of LF protease from B. anthracis 2. Method:
Regulation of Glycogen Metabolism Protein Kinases Protein Phosphatases cAMP G proteins Calcitonin Insulin, glucagon, and epinephrine.
Enzyme Kinetics.
Michaelis-Menten kinetics
Chapter 6: Energy and Metabolism. Biological Work Requires Energy Remember to study the terms Energy Concepts Video.
Investigation of the enzymatic processes depending on the type of reaction.
Biochemistry 412 Enzyme Kinetics II April 1st, 2005.
Enzyme Kinetics Sadia Sayed. What is Enzyme Kinetics?  Kinetics is the study of the rates at which chemical reactions occur  Then what is Enzyme Kinetics?
Key topics about enzyme function:
Practical Enzyme Kinetics
Enzyme Kinetics provides Insight into
Chemical Reactions Review
Volume 3, Issue 5, Pages e2 (November 2016)
Masahiro Ueda, Tatsuo Shibata  Biophysical Journal 
Identify and Investigate the role of enzymes.
ENZYME Enzymes as organic catalysts. Factor affecting enzyme activity.
Volume 113, Issue 12, Pages (December 2017)
TCR Binding to Peptide-MHC Stabilizes a Flexible Recognition Interface
Volume 3, Issue 5, Pages e2 (November 2016)
Enzymes Homeostasis: property of living organisms to regulate their internal environment, maintaining stable, constant condition *Occurs by multiple adjustments.
Kenneth Tran, Nicolas P. Smith, Denis S. Loiselle, Edmund J. Crampin 
Brian L. Sprague, Robert L. Pego, Diana A. Stavreva, James G. McNally 
Kenton J. Swartz, Roderick MacKinnon  Neuron 
Presentation transcript:

Irreversible Inhibition Kinetics1 Automation and Simulation Petr Kuzmič, Ph.D. BioKin, Ltd. 1.Automate the determination of biochemical parameters 2.PK/PD simulations with multiple injections Irreversible Inhibition Kinetics

2 Automation and Simulation Petr Kuzmič, Ph.D. BioKin, Ltd. 1.Automate the determination of biochemical parameters 2.PK/PD simulations with multiple injections Irreversible Inhibition Kinetics

3 EGFR inhibition by covalent drugs Schwartz, P.; Kuzmic, P. et al. (2014) “Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance” Proc. Natl. Acad. Sci. USA. 111, Issue 1, January 7 Initial estimates Suitable initial estimates of rate constants were discovered by trial and error. Outlier rejection Certain “defective” progress curves were manually excluded from analysis. PRACTICAL CHALLENGES: This “manual” method is not ideally suited for routine production environment.

Irreversible Inhibition Kinetics4 Full automation: Five passes through raw data Piecewise linear fit: Eliminate “defective” progress curves “Local” algebraic fit of reaction progress: Determine offsets and initial rates Algebraic fit of initial rates: Determine K i (app) for initial non-covalent complex Global numerical fit of reaction progress: Pass #1 Determine k inact, K i, and k inact /K i under rapid-equilibrium approximation Global numerical fit of reaction progress: Pass #2 Estimate lower limits for k on and k off under steady-state approximation

Irreversible Inhibition Kinetics5 Full automation: Sharing of intermediate results Piecewise linear fit “Local” algebraic fit of reaction progress Algebraic fit of initial rates Global numerical fit: Pass #1 Global numerical fit: Pass #2 mark-up of raw data files initial rates baseline offsets K i (app) KiKi k inact, k inact /K i k on k off k inact lower limit estimate

Irreversible Inhibition Kinetics6 Full automation: Implementation - Scripting Master script (Perl) Perl script: QA/QCDynaFit Perl script: initial ratesDynaFit Perl script: K i (app) DynaFit Perl script: k inact, K i DynaFit Perl script: k on, k off DynaFit

Irreversible Inhibition Kinetics7 Quality control of raw data: Piecewise linear fit - Method 1.Fit progress curves to three linear segments. 2.Examine the linear slopes in each segment. 3.If the slope in either the second or the third segment is negative reject the entire progress curve. 4.Reject also corresponding curves from remaining replicates.

Irreversible Inhibition Kinetics8 Quality control of raw data: Piecewise linear fit - Results AcceptReject

Irreversible Inhibition Kinetics9 Quality control of raw data: Piecewise linear fit - Summary NOTE: Each assay will require its own of set of heuristic QA/QC rules!

Irreversible Inhibition Kinetics10 Local algebraic fit to determine initial rates - Method Fit fluorescence vs. time to an exponential equation t... time v i... initial reaction rate k obs... first-order rate constant F... fluorescence signal at time t F 0... instrument baseline r P... concentration-to-signal scaling parameter [P]... product concentration at time t Reused in subsequent steps of the fully automated system

Irreversible Inhibition Kinetics11 Local algebraic fit to determine initial rates - Results reused ignored

Irreversible Inhibition Kinetics12 Algebraic fit of initial rates - Method “Morrison equation” for tight-binding enzyme inhibition: A little twist: Optimize [E] 0 but only within a narrow range (up to [E] nominal ). See Kuzmic P., et al. (2000) Anal. Biochem. 286,

Irreversible Inhibition Kinetics13 Algebraic fit of initial rates - Results K i (app) = (6.3 ± 0.8) nM Used to make the initial estimate of k (off) in global fit of progress curves k (off) = K i (app)  k (on)

Irreversible Inhibition Kinetics14 Global fit of reaction progress - Method “Generalized mechanism” (no longer simplified “Hit-and-Run” model): [mechanism] ; “T” = ATP, “D” = ADP E + T E.T : kaT kdT S + E.T S.E.T : kaS kdS S.E.T ---> P + E + D : kcat E + I E.I : kaI kdI E.I ---> E-I : kinact S + E.I S.E.I : kaS kdS S.E.I ---> S.E-I : kinact S.E-I S + E-I : kdS kaS DynaFit notation

Irreversible Inhibition Kinetics15 Global fit of reaction progress - Results k (off) little or no correlation Correlation of biochemical rate constants with cellular potency k (on) strong correlation

Irreversible Inhibition Kinetics16 Automation and Simulation Petr Kuzmič, Ph.D. BioKin, Ltd. 1.Automate the determination of biochemical parameters 2.PK/PD simulations with multiple injections Irreversible Inhibition Kinetics

17 Possible cellular mechanism protein re-synthesis protein degradationdrug eliminationprotein degradation REALISTIC PK/PD MODEL MUST ACCOUNT FOR METABOLISM OF PROTEIN AND DRUG MOLECULES

Irreversible Inhibition Kinetics18 Possible cellular mechanism in DynaFit software DYNAFIT USES “SYMBOLIC” REPRESENTATION OF ARBITRARY MOLECULAR MECHANISM [task] task = simulate data = progress [mechanism] E + I E.I : kon koff E.I ---> E~I : kinact I ---> X : kout ---> E : ksyn E ---> X : kdeg E~I ---> X : kdeg... Example DynaFit input:

Irreversible Inhibition Kinetics19 DynaFit simulation output: Afatinib – strong inhibitor target concentration, % time, seconds (total = 72 hours) increasing [inhibitor] kon = 18 koff = kinact = Afatinib:

Irreversible Inhibition Kinetics20 Simulate multiple injections - Method 1.Set initial concentrations of [Enzyme] and [Inhibitor] 2.Run a DynaFit simulation for one injection 3.Record concentrations at the end of the run 4.Increase [Inhibitor] concentration by next injection amount 5.Set initial concentrations to the final values (after adjusting [I]) 6.Go to step #2 above

Irreversible Inhibition Kinetics21 Multiple injections: Implementation - Scripting Master script (Perl) DynaFit Master script input: kon = ; binding koff = ; dissociation kinact = ; covalent inactivation kelim = ; 3 h drug half-life kpsyn = ; uM per 12 h * ln(2) kpdeg = ; 12 h protein half-life E = EI = 0 EJ = 0 I = 0.01 ReinjectI = 0.01 Mesh = linear from 0 to step 600 ; 12 hours total Injections = 10...

Irreversible Inhibition Kinetics22 Multiple injections: Results Compound 2: strong inhibitor Compound 4: weak inhibitor simulate hours each:

Irreversible Inhibition Kinetics23 Multiple injections: Results – Increase injection frequency Compound 5: intermediate inhibitor inject every 12 hours inject every 8 hours

Irreversible Inhibition Kinetics24 Multiple injections: Results – Decrease injection frequency Compound 5: intermediate inhibitor inject every 12 hours inject every 24 hours

Irreversible Inhibition Kinetics25 Simulating multiple injections: Summary and conclusions DynaFit does not have to be enhanced or modified to do PK/PD simulations PK/PD module can be implemented as a simple Perl script Perl scripts are simple text files: can be modified by any programmer RESULTS (not shown): IMPLEMENTATION: Association (“on”) rate constants are very important for PK/PD outcome Dissociation (“off”, “residence time”) rate constants appear less important CAVEAT: Highly reliable values for “on” / “off” rate constants are needed!